Orphazyme Fundamentals

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>OR</div>
ORPHA -- Denmark Stock  

DKK 104.60  0.80  0.76%

Orphazyme fundamental analysis lookup allows you to check this and other indicators for Orphazyme AS or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Fundamentals

 
Refresh

Orphazyme Number of Employees Analysis

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was founded in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark.
Number of Employees 
 = 
Full Time 
+  
Part Time 
More About Number of Employees | All Equity Analysis

Current Orphazyme AS Number of Employees

86

About Number of Employees

Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Compare to competition
Based on recorded statements Orphazyme AS is currently employing 86 people. This is 99.22% lower than that of the Healthcare sector, and 83.94% lower than that of Biotechnology industry, The Number of Employees for all stocks is 99.54% higher than the company.

Orphazyme AS Fundamental Drivers Relationships

Orphazyme AS is considered to be number one stock in ebitda category among related companies. It is considered to be number one stock in cash and equivalents category among related companies .
Orphazyme AS is considered to be number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is now estimated at about 91.0. Orphazyme totals roughly 86.0 in number of employees claiming about 95% of stocks in Biotechnology industry.

Orphazyme Fundamentals

About Orphazyme Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Orphazyme AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orphazyme using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orphazyme AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.
Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was founded in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark.

 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page